LAUSANNE, Switzerland--(BUSINESS WIRE)--Galderma today announced a European re-launch of Sculptra ® (injectable poly-L-lactic acid) - a collagen stimulator - with an updated administration protocol.

Please provide your email address to receive an email when new articles are posted on . At 15 months post-treatment, 84.8% of patients achieved improvement in cheek wrinkle severity. No new safety ...

SCULPT & LIFTTM pairs Restylane® Lyft or Restylane® Contour with Sculptra® to help restore a youthful appearance and your ...

July 30, 2009 — The US Food and Drug Administration (FDA) has approved injectable poly-L-lactic acid (Sculptra Aesthetic, sanofi-aventis US) for use in immune-competent people to correct shallow to ...

Please provide your email address to receive an email when new articles are posted on . Sculptra is the first and original injectable poly-L-lactic acid approved for the correction of cheek wrinkles.

Galderma unveils We Are All Sculptra, a global campaign capturing the clinical performance of Sculptraacross nine diverse patient profiles and journeys, over two years1 Backed by over 25 years ...

-- Galderma celebrates the 25th anniversary of the approval of Sculptra(R), the first proven regenerative biostimulator, with new data, another approval, and expanding treatment applications1-5 -- New ...

With a proven ability to restore skin thickness, firmness, and radiance through collagen stimulation, Sculptra ® remains a trusted solution for achieving naturally rejuvenated skin. “As part of the ...

FORT WORTH, Texas--(BUSINESS WIRE)--Galderma, the leading company solely dedicated to advancing the future of dermatology, announced it will present four scientific presentations at the 2022 Vegas ...